↓ Skip to main content

Postmenopausal Osteoporosis

Overview of attention for article published in New England Journal of Medicine, May 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

twitter
10 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Postmenopausal Osteoporosis
Published in
New England Journal of Medicine, May 2016
DOI 10.1056/nejmc1602599
Pubmed ID
Authors

Black, Dennis M, Rosen, Clifford J

Abstract

To the Editor: According to the results of two trials presented in Table 3 of the article by Black and Rosen (Jan. 21 issue),(1) the first 3 years of bisphosphonate use are beneficial for the prevention of fracture. However, the data presented in the table are misleading. The steep increase in the incidence of atypical fracture with prolonged bisphosphonate use is concomitant with little or no added efficacy in the prevention of fracture. On the basis of population-based data,(2) rather than theoretical calculations,(1) the risk of atypical femoral fractures for patients who receive 4 years of treatment is 126 times . . .

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2016.
All research outputs
#5,520,041
of 22,875,477 outputs
Outputs from New England Journal of Medicine
#19,436
of 30,785 outputs
Outputs of similar age
#88,021
of 337,040 outputs
Outputs of similar age from New England Journal of Medicine
#245
of 294 outputs
Altmetric has tracked 22,875,477 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 30,785 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 117.4. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 337,040 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 294 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.